相关实验视频

Updated: Jul 10, 2025

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging

Published on: July 1, 2021

米拉贝格朗通过全球色脂肪组织表现出抗癌作用

Xiaoting Sun^1,2, Wenhai Sui³, Zepeng Mu⁴

¹Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vison and Brain Health), School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.

Nature communications

|November 22, 2023

概括

膀药物Mirabegron通过色脂肪组织显示出强大的抗癌作用. 这种新的治疗方法针对代谢重编程,为治疗各种癌症提供了新的希望,包括难以治疗的癌症类型.

科学领域:

在瘤学瘤学.
代谢研究的研究.
药理学药理学是指药理学的学科.

背景情况:

癌细胞表现出代谢重编程,依靠糖解来进行生长和转移.
脂肪代谢在瘤进展和治疗向中的作用仍未得到充分研究.
准代谢途径为新型癌症疗法提供了一个有希望的途径.

研究的目的:

研究向脂肪代谢治疗癌症的潜力.
为了评估Mirabegron的抗癌疗效,这是一种治疗过度活跃膀的药物.
为了阐明mirabegron在癌症治疗中的作用机制.

主要方法:

利用各种动物癌症模型来测试mirabegron的疗效.
研究了脂肪组织色在调解抗癌效应中的作用.
研究了脱蛋白1 (UCP1) 的遗传删除和棕色脂肪组织的去除的影响.

主要成果:

米拉贝格朗在各种癌症模型中表现出显著的抗癌作用,包括胰腺癌和肝癌.
药物的有效性与脂肪组织的色直接相关.
基因切除UCP1或切除棕色脂肪组织可以消除Mirabegron的抗癌活性.

结论:

米拉贝格朗代表了一种具有独特作用机制的新型抗癌药物.
准脂肪组织色为多种癌症类型提供了一个新的治疗策略.
米拉贝格朗的重用具有治疗难治癌症的潜力.

更多相关视频

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice

Published on: February 3, 2023

相关概念视频

Cholinergic Antagonists: Pharmacological Actions

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...